Medication info

Glutathione Injection

Prescription medicationInjections
Ingredient · strength
L-Alanine›1.6g / 100mLL-Arginine›1.13g / 100mLL-Aspartic Acid›0.34g / 100mLL-Glutamic Acid›0.56g / 100mLGlycyl-L-Glutamine›3.027g / 100mLGlycyl-L-Tyrosine›0.345g / 100mLL-Histidine›0.68g / 100mLL-Isoleucine›0.56g / 100mLL-Leucine›0.79g / 100mLL-Lysine Acetate›1.27g / 100mLL-Methionine›0.56g / 100mLL-Phenylalanine›0.585g / 100mLL-Proline›0.68g / 100mLL-Serine›0.45g / 100mLL-Threonine›0.56g / 100mLL-Tryptophan›0.19g / 100mLL-Valine›0.73g / 100mL
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
A colorless to pale yellow transparent liquid contained in a polypropylene aqueous injection bottle
Packaging
500mL/pack
Approval status
Active

MFDS item code 200300193 · Notified 2003.07.24

Summary

Main use
Prevention of amino acid deficiency in patients unable to receive oral or gastrointestinal nutritional support
Who uses it
Adults
Adult dosage
Dose: Infuse a total of 1~2 g/kg body weight per day of amino acids/dipeptides (equivalent to 0.17~0.34 g nitrogen) slowly. This corresponds to 7~14 mL/kg body weight per day of this medication; for a patient weighing 70 kg, administer 500~1000 mL daily. Infusion rate: 0.6 ~ 0.7 mL/kg body weight per hour (equivalent to 0.08~0.09 g of total amino acids/dipeptides) is recommended.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Prevention of amino acid deficiency in patients unable to receive oral or gastrointestinal nutritional support

View approved original text

This drug is used for patients who have difficulty or insufficient nutritional supply through oral intake or the gastrointestinal tract. It provides amino acids to improve nutritional status, especially in individuals with moderate to severe worsening of nutritional status. This helps maintain and recover physical strength and contributes to health recovery.

Dosage and Administration

Adult dosage

Dose: Infuse a total of 1~2 g/kg body weight per day of amino acids/dipeptides (equivalent to 0.17~0.34 g nitrogen) slowly. This corresponds to 7~14 mL/kg body weight per day of this medication; for a patient weighing 70 kg, administer 500~1000 mL daily. Infusion rate: 0.6 ~ 0.7 mL/kg body weight per hour (equivalent to 0.08~0.09 g of total amino acids/dipeptides) is recommended.

Precautions

This drug must only be used according to a physician's instructions. It should not be used in patients with congenital metabolic disorders of amino acids, such as phenylketonuria. Patients with severe liver or kidney dysfunction should not take this drug. It should not be administered to patients who face life-threatening conditions due to severe cardiovascular problems. This drug is also unsuitable for patients with metabolic acidosis, i.e., those who have excessively high acidity in the body. It should not be used in patients with inadequate oxygen supply or excessive fluid in the body. Patients with low sodium or potassium levels in the blood should not be administered this drug. Patients with excessive lactic acid accumulation, i.e., lactic acidosis, should also avoid this drug. It is unsuitable for patients with heightened blood osmotic pressure. Patients with pulmonary edema from fluid accumulation in the lungs and those with severe cardiac failure should also avoid this drug. Patients who show allergic reactions to any of its components should not use it. This drug should not be administered to children under 2 years of age. Patients with a history of myocardial infarction or current myocardial infarction should also not use this drug. When administered correctly, no special side effects have been reported. However, if injected too quickly, discomfort, chills, nausea, vomiting, facial flushing, or sweating may occur. In such cases, the rate of drug administration should be reduced or temporarily stopped. There may be temporary liver function deterioration resulting in diarrhea, headache, paralysis, elevated body temperature, itching, or a sensation of heat. During the use of this drug, electrolyte concentrations, osmotic pressure, fluid balance in the body, acid-base status, and liver function levels should be regularly monitored. Currently, there are no known interactions with other drugs. Pregnant or lactating women may only use this drug if the therapeutic benefits are considered to outweigh the risks. Absolutely do not use in children under 2 years of age, and experience with children over 3 years old is limited, so it is not recommended. This drug should only be used when the container is undamaged and the solution is clear. Unused portions should not be reused. When storing this drug, soft bag products do not require a separate needle, while vial products should be prepared appropriately just before use, such as puncturing with an appropriate venting needle. Do not use if the solution is discolored, leaked, or if droplets are present on the packaging. Do not use if the film protecting the rubber stopper has been removed. When using the drug, the indicated measurement on the container must be strictly followed.

Side effects

Intolerance symptoms, chills, nausea, vomiting, flushing, sweating, renal excretion symptoms of amino acids and dipeptides, diarrhea, headache, paralysis, elevated body temperature, itching, sensation of heat

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container that prevents air intrusion and is best kept at a cool temperature below 25 degrees Celsius. This will help maintain the drug's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

A colorless to pale yellow transparent liquid contained in a polypropylene aqueous injection bottle

Package unit

500mL/pack

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.